Natera Officer Sells $1.4M in Common Stock Under Rule 10b5-1 Plan
Natera, Inc.
Subscribe to track NTRA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction Alert: Natera, Inc. (NTRA)
**Insider:** Solomon Moshkevich
**Title:** President, Clinical Diagnostics
**Filing Date:** 2026-11-04
**Transaction Date:** 2026-11-02
### Transaction Summary
* **Type:** Sale (Open Market)
* **Shares Sold:** 3,419
* **Average Price:** ~$409.77 (Range: $388.20 - $416.73)
* **Total Proceeds:** ~$1,400,994.50
* **Post-Transaction Holdings:** 101,323 shares
### Key Context
* 419 shares were sold to satisfy tax withholding obligations upon RSU vesting.
* 3,000 shares were executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on November 26, 2024.
* Insider continues to retain >96% of their prior holding.
Comprehensive Analysis
Executive Summary
On November 2, 2026, Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NTRA), disposed of a total of 3,419 shares of common stock across multiple tranches for aggregate proceeds of approximately $1.40 million at an average weighted price of $409.77 per share.
Transaction Breakdown
-
Tax Withholding / Sell-to-Cover (419 shares):
- 9 shares sold at $388.2001
- 410 shares sold at $400.2942
- These sales were mandated to cover tax remittance obligations resulting from the vesting of restricted stock units (RSUs) pursuant to written instructions intended to comply with Rule 10b5-1(c).
-
10b5-1 Pre-Arranged Plan Sales (3,000 shares):
- Executed across 10 separate price bands ranging from $404.85 to $416.73 per share.
- Carried out under a Rule 10b5-1 trading plan established on November 26, 2024.
Ownership Impact & Market Significance
- Holding Impact: Following the transaction, Moshkevich directly holds 101,323 shares of Natera common stock, representing a modest ~3.26% reduction of his pre-transaction holdings (104,742 shares).
- Significance Level: Low. The routine nature of RSU tax withholdings paired with the execution of a pre-set Rule 10b5-1 plan adopted nearly two years prior indicates these transactions are programmatic liquidity events rather than discretionary signals regarding company fundamentals.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.